Back to search

France· FR:62645506

VICTOZA 6 mg/ml, solution injectable en stylo prérempli

A liraglutide product containing liraglutide, registered in France by NOVO NORDISK (DANEMARK), on the national reimbursement list. The same ATC class is registered in 16 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC A10BJ02

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedVICTOZA 6 mg/ml, solution injectable …ATCA10BJ02REGISTER NO.FR:62645506PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Liraglutide is registered in 16 of 19 countries.

Countries holding a registration under ATC A10BJ02 (liraglutide), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 10 of them publish a price we can compare per daily dose

Liraglutide · ATC A10BJ02

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
LIRAGLUTIDE
Manufacturer
NOVO NORDISK (DANEMARK)
Country
France (FR)
ATC code
A10BJ02
ATC class
Liraglutide
Defined daily dose
1.5 mg, P
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400939632360
    2 cartouche(s) en verre dans stylo pré-rempli de 3 ml
    EUR 48.42

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

309 interactions on record for liraglutide.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Liraglutide · interactions on record

309 records

  • 3 severe
  • 260 moderate
  • 46 minor

Most severe, free to view

  • GatifloxacinJ01MA16severe
  • SucralfateA02BX02moderate
  • ThiethylperazinA04AB03moderate
  • TriflupromazinA04AD06moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Liraglutide in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All liraglutide products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Austria · Ejulir, Lirabelin
  • Belgium · Byesilor, Zinnentis
  • Bulgaria · Зеглуксен
  • Czechia · Ejulir, Plyzari
  • Germany · Byesilor, Diavic
  • Denmark · Ejulir, Liraglutid "biogaran"
  • Estonia · Liraglutide Zentiva, Siluxir
  • Spain · Byesilor, Diavic
  • Finland · Diavic, Metlyra
  • United Kingdom (Northern Ireland) · Diavic, Ligobesy
  • Croatia · Zegluxen
  • Hungary · Liendax
  • Ireland · Ejulir
  • Iceland · Ablymico, Liraglutide Stada
  • Italy · Byesilor, Diavic
  • Liechtenstein · Ablymico, Liraglutide Stada
  • Lithuania · Liraglutide Zentiva
  • Luxembourg · Zinnentis
  • Latvia · Liraglutide Zentiva, Siluxir
  • Netherlands · Byesilor, Diavic
  • Norway · Ablymico, Liraglutid Zentiva
  • Poland · Byesilor, Diavic
  • Portugal · Liraglutido Farmoz, Liraglutido Pentafarma
  • Romania · Byesilor, Diavic
  • Sweden · Diavic, Ejulir
  • Slovakia · Sudaclin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d6569f77-3b02-49fc-b86a-bb970f26c580
GET /v1/drugs/d6569f77-3b02-49fc-b86a-bb970f26c580?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "62645506",
  "date_amm": "2009-06-30",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/09/529",
  "substance": "LIRAGLUTIDE",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution injectable",
  "voies_administration": "sous-cutanée",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about liraglutide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.